Literature DB >> 3284394

Evidence for lack of importance of oxygen free radicals in Escherichia coli endotoxemia in dogs.

M J Novotny1, M H Laughlin, H R Adams.   

Abstract

Reactive oxygen species have been proposed as pathophysiological factors responsible for the hypodynamic circulatory response to gram-negative endotoxin. To test this hypothesis, we examined the cardiorespiratory effects of mechanistically different oxygen free radical scavenging agents during Escherichia coli endotoxemia in beagle dogs. Pentobarbital-anesthetized dogs were instrumented for repeated sampling of cardiorespiratory, hematologic, and tissue blood flow (radiolabeled 15-micron microspheres) indexes. Four groups were studied: 1) time-matched control dogs (n = 6); 2) dogs receiving only endotoxin (1.5 mg/kg; n = 6); 3) dogs receiving endotoxin and combination therapy with allopurinol (150 mg/kg) plus superoxide dismutase (5 mg/kg) and catalase (5 mg/kg; n = 6); and 4) dogs receiving endotoxin and deferoxamine (30 mg/kg; n = 5). Measured variables in control dogs were constant during the 4-h study, whereas endotoxin-injected dogs consistently demonstrated the following: 1) maintained reductions in blood pressure (greater than 45%), left ventricular systolic pressure (greater than 43%), left ventricular maximum rate of pressure development (+/- dP/dtmax) (greater than 41%), cardiac index (greater than 33%), and blood flow in all sampled tissues except liver and skeletal muscle; 2) transient tachypnea, bradycardia, and arterial acidosis; and 3) persistent neutropenia and hemoconcentration. Neither of the free radical scavenging protocols significantly improved measured variables during endotoxemia (P greater than 0.05). This lack of efficacy suggests that superoxide anion, hydrogen peroxide, and hydroxyl radical may lack primary pathophysiological importance during the development of E. coli endotoxicosis in intact dogs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284394     DOI: 10.1152/ajpheart.1988.254.5.H954

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Plasma lipid peroxides and antioxidants in human septic shock.

Authors:  A C Ogilvie; A B Groeneveld; J P Straub; L G Thijs
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 2.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

3.  Characteristics of neutrophil influx in rat lungs following fecal peritonitis.

Authors:  J G Peralta; M L Barnard; J F Turrens
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

4.  Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation.

Authors:  Cristiane Ritter; Michael Andrades; Mário Luis C Frota Júnior; Fernanda Bonatto; Ricardo A Pinho; Manuela Polydoro; Fábio Klamt; Cleovaldo T S Pinheiro; Sérgio S Menna-Barreto; José Cláudio F Moreira; Felipe Dal-Pizzol
Journal:  Intensive Care Med       Date:  2003-05-29       Impact factor: 17.440

5.  Polyethylene glycol-superoxide dismutase prevents endotoxin-induced cardiac dysfunction.

Authors:  Gerald S Supinski; Leigh A Callahan
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

6.  In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates.

Authors:  C K Edwards; S M Ghiasuddin; L M Yunger; R M Lorence; S Arkins; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Preservation of renal blood flow by the antioxidant EUK-134 in LPS-treated pigs.

Authors:  Sheldon Magder; Dimitrios G Parthenis; Imad Al Ghouleh
Journal:  Int J Mol Sci       Date:  2015-03-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.